CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 60 enrolled
Drug / intervention
Ketamine Versus Bupivacainedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05097118
NCT05097118Early Ph 1Completed
CompareCT.gov

Surgical Site Infiltration Using Ketamine Versus Bupivacaine for Analgesia in Post-operative Appendectomy Operation

Sohag University·interventional·Posted Oct 27, 2021·Updated Oct 18, 2022

In Brief

A Early Phase 1 clinical trial evaluating Ketamine Versus Bupivacaine for Appendicitis Acute. Completed, enrolled 60 participants across 1 site.

Detailed Summary

surgical site infiltration using ketamine versus Bupivacaine for analgesia in post-operative Appendectomy operation by Ketamine versus Bupivacaine

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAppendicitis Acute
CountriesEgypt
Collaborators--

Timeline

Early Ph 1CompletedFinished
20222023202420252026
First PostedOct 27, 2021
Enrollment StartSep 1, 2021
Primary CompletionMay 1, 2022
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 4.7 years ago

Interventions

Ketamine Versus Bupivacainedrug

Drugs Ketamine versus Bupivacaine